Alona Zer, Christine Ratajczak, Hephzibah Adamu, Shilpen Patel, Zhuangzhuang Liu, Summer Xia, Nancy Zhang. "TeliMET NSCLC-04: A phase 2, open-label, randomized, global study of 2 telisotuzumab vedotin regimens in patients with previously treated c-Met protein–overexpressing, locally advanced/metastatic non-squamous
            <i>EGFR</i>
            wildtype non-small cell lung cancer.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps8658